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Mitochondrial Fission Factor (MFF) is part of a protein complex that promotes
mitochondria and peroxisome fission. Hitherto, only 5 patients have been reported
harboring mutations in MFF, all of them with the clinical features of a very early
onset Leigh-like encephalopathy. We report on an 11-year-old boy with epileptic
encephalopathy. He presented with neurological regression, epileptic myoclonic
seizures, severe intellectual disability, microcephaly, tetraparesis, optic atrophy, and
ophthalmoplegia. Brain MRI pattern was compatible with Leigh syndrome. NGS-based
analysis of a gene panel for mitochondrial disorders revealed a homozygous c.892C>T
(p. Arg298∗) in the MFF gene. Fluorescence staining detected abnormal morphology
of mitochondria and peroxisomes in fibroblasts from the patient; a strong reduction in
MFF protein levels and the presence of truncated forms were observed. No biochemical
alterations denoting peroxisomal disorders were found. As reported in other disorders
affecting the dynamics of intracellular organelles, our patient showed clinical features
suggesting both mitochondrial and peroxisomal impairment. High levels of lactate in our
case suggested an involvement of the energetic metabolism but without clear respiratory
chain deficiency, while biomarkers of peroxisomal dysfunction were normal. We confirm
that MFF mutations are associated with epileptic encephalopathy with Leigh-like MRI
pattern.
Keywords: mitochondrial fission factor, MFF, epileptic encephalopathy, leigh syndrome, mitochondrial disorders,
mitochondria, peroxisome
INTRODUCTION
Mitochondria are dynamic organelles and their morphology results from a finely tuned balance
between fusion and fission events. These processes are particularly important for the maintenance
of the cellular homeostasis: fission in particular allows quality control over the mitochondrial
network, by separating defective mitochondria that are then targeted to mitophagy, and it
is mediated by a series of nuclear-encoded proteins. Impairment in mitodynamics has been
associated with diverse pathological conditions, including monogenetic forms of mitochondrial
disorders caused by mutations affecting key players of this system. Dynamin-related protein 1
(DRP1, encoded by the DNM1L gene–MIM603850) is the main effector of mitochondrial fission
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but it also contributes to the division of peroxisomes (Li and
Gould, 2003). DRP1 is mainly distributed in the cytoplasm and
need proper cellular signals to be recruited to the mitochondria
where it multimerizes creating a ring-like structure that separates
the organelle. Several DRP1 receptors and recruitment factors
on the outer mitochondrial membrane have been identified,
including MFF (Mitochondrial fission factor–MIM614785),
FIS1/TTC11 (Mitochondrial fission 1–MIM609003), GDAP1
(ganglioside-induced differentiation-associated protein 1–
MIM606598) and MIEFs (Mitochondrial Elongation Factors;
i.e., MIEF1-MIM615497 and MIEF2-MIM615498, also known as
MiD51/MiD49). Notably, mutations in genes encoding some of
these proteins have been associated with human disorders. For
instance, genetic defects in DNM1L result in phenotypes varying
from autosomal dominant optic atrophy to severe early onset
mitochondrial encephalopathy, while mutations in GDAP1 have
been linked to forms of Charcot Marie Tooth Disease (Archer,
2013).
The outer membrane protein MFF is an essential component
of the conserved machinery for membrane fission of
mitochondria and peroxisomes, and presumably the major DRP1
receptor for organelle fission. Knockdown of MFF results in
mitochondrial elongation and formation of tubular peroxisomes
(Otera et al., 2010; Itoyama et al., 2013). Immunoprecipitation
FIGURE 1 | Brain magnetic resonance images of the proband. (A–C) Images taken at 4 years; (D–F) images taken at 8 years. (A) T2 axial, (B) T2 coronal, (C) T1
sagittal, (D) T2 axial, (E) T2 coronal, (F) T2 sagittal. A-D: bilateral inhomogeneous lesions of the Putamen and of the Caudatum. (B–E,F) Progressive cerebellar
(vermian and hemispheric) atrophy. (C–F) Thin corpus callosum.
studies suggested MFF is part of a high-molecular weight
complex including other proteins but not DRP1 (Gandre-Babbe
and van der Bliek, 2008).
Biallelic mutations in MFF have been reported to be the
cause of “Encephalopathy due to defective mitochondrial and
peroxisomal fission 2” (EMPF2; MIM#617086), an extremely
rare, autosomal recessive disorder characterized by delayed
psychomotor development, severe hypotonia, and abnormal
signals in the basal ganglia (Shamseldin et al., 2012; Koch et al.,
2016).
We report here on the clinical and biochemical features of an
11-year-old Italian boy with epileptic encephalopathy, in whom
we found a homozygous nonsense mutation in theMFF gene.
METHODS
Genetic Studies
Informed consent for genetic analyses was obtained from the
child’s parents. The study was approved by the Ethical Committee
of the Neurological Institute Besta. Written informed consent
was obtained from the guardian of the patient for the publication
of this case report. Genomic DNA was extracted from peripheral
blood using standard method. Next generation sequencing of a
panel of 230 nuclear genes associated withmitochondrial diseases
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was performed by MiSeq (Illumina), followed by bioinformatics
analysis, as previously described (Legati et al., 2016).
Immunoblotting
For western blot analysis, fibroblasts from patient and controls
were pelleted and solubilized in RIPA buffer with protease
inhibitors; 40 µg of protein was loaded for each sample
in 12% denaturing sodium-dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE). Polyclonal antibodies against
DRP1 (D6C7, #8570, Cell Signaling, 1:1000) and against MFF
(17090-1-AP, Proteintech, 1:1000), and a monoclonal antibody
against GAPDH (#MAB374, Millipore, 1:1000) were used.
Fluorescence Microscopy
Skin fibroblasts were cultured in a 37◦C incubator with 5% CO2,
in either 25mM glucose or 5mM galactose Dulbecco’s Modified
EagleMedium-DMEM (Euroclone) supplementedwith 10% FBS,
1% L-glutamine and 0.2% sodium pyruvate. For visualization
of the mitochondrial network, the mitochondrial fluorescent
dye MitoTracker Red-CMXRos (Invitrogen) was added to
culture media at a final concentration of 50 nM for 30min
and then images were acquired, in live cells, with a confocal
microscope (Leica TSC-SP8). For visualization of peroxisomes,
after fixation and permeabilization, cells were incubated with
a polyclonal antibody anti-PMP70 (Millipore, 1:200), followed
by a fluorescently labeled secondary antibody Alexa Fluor 488
(Invitrogen, 1:1000); then images were acquired with a confocal
microscope (Leica TSC-SP8) using a 63x oil objective.
Analysis of mitochondrial network and peroxisomal
morphology was conducted using the image processing package
ImageJ (Fiji). Images were then binarized, thresholded, and
subjected to particle analysis to acquire form factor (“circularity”:
4pi∗area/perimeter2). A value of 1.0 indicates a perfect circle;
values approaching to 0.0 indicate increasingly elongated shapes.
Data were analyzed using unpaired two-tailed Student’s t-tests.
RESULTS
Case Study
The proband was an 11 year-old Italian boy born from
consanguineous (first cousins) parents after a pregnancy
characterized by intrauterine growth retardation. The pedigree
included an older brother with an early onset severe epileptic
encephalopathy, who died at 16 years, and another healthy
brother. Moreover, a previous pregnancy of the mother resulted
in a spontaneous miscarriage in the first trimester.
At birth, his weight was 2.5 kg (<5th percentile), length
was 47 cm (<5th percentile) and head circumference was
FIGURE 2 | Molecular and protein studies in a patient with MFF mutation. (A) Snapshot from IGV software of the mutation identified in the proband. (B,C) Pedigree of
the family and electropherograms of the MFF region containing the c.892C>T variant. The black symbols indicate the clinically affected subjects. (D) Schematic
representation of the MFF protein. Functional domains are in color: Short repeat (SR) in green; coiled-coil (CC) in yellow; transmembrane (TM) in blue. (E) Immunoblot
analysis of total lysates from control subjects (Ct1 and Ct2) and patient’s (Pt) fibroblasts using α-MFF, α-DRP1 and α-GAPDH antibodies. The latter was used as
loading control. Two different exposure times are reported for MFF. (F) Densitometric analysis of the immunoblots. The levels of MFF and DRP1 proteins were
normalized against GAPDH and expressed as percentage relative to the average of all controls. Data are presented as mean ± SD of three experiments.
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33 cm (5th percentile), his postnatal adaptation was normal.
Neonatal period was unremarkable. The proband showed a
normal psychomotor development until the age of 9 months,
when neurological regression was observed. Epileptic seizures
emerged at the age of 18 months and were characterized by
oro-buccal automatisms, lids myoclonias, hyperventilation with
cyanosis and slow anteflexion of the head. At that time, critical
EEGs showed rapid activity with rhythmic anteriorly dominant
spikes and atypical spike-wave complexes.. On evaluation, at 20
months of age, the child presented with microcephaly, failure to
thrive, mild dysmorphic features (epicanthus, long philtrum) and
exotropia. He appeared hyporeactive and inconstantly responsive
when called, with reduced finalistic movements, and showed
severe axial hypotonia, with poor head and trunk control, and
spasticity with distal dystonic postures of the limbs. In the
following years the epileptic phenotype changed into clonic and
tonic-clonic seizures associated with oro-buccal automatisms.
EEGs were characterized by multifocal spikes, polispikes and
atypical spike-wave complexes in a context of disorganized
background activity. Mild hepatic steatosis and cholestasis were
also detected at 4 years of age, which improved during the
course of the years. Last liver ultrasound examination was
performed at 10 years of age and didn’t show any remarkable
alteration. Brain MRIs showed bilateral lesions of putamen,
globus pallidus, caudate, and dentate nuclei, compatible with the
diagnosis of Leigh Syndrome (Figures 1A–C). On examination
at the age of 5 years he showed: severe intellectual disability,
microcephaly, spastic-dystonic tetraparesis, severe optic atrophy,
and ophthalmoplegia. An extensive metabolic work-up showed
lactic acidosis (maximum value: 3.2 mmol/l; reference values
0.5–1.2 mmol/L), and increased lactate in CSF (26.23 mg/dL;
reference values 2.25–10 mg/dL) and in the brain (by 1H-MRS);
very long chain fatty acids (VLCFA), phytanic and pristanic acids,
docosahexaenoic acid (DHA), di- and trihydroxycholestanoic
acid (DHCA and THCA) were normal. Respiratory chain
complex activities in muscle biopsy and fibroblasts, as well as
pyruvate dehydrogenase (PDH) activity in fibroblasts, were in
the control range. Bioenergetic parameters, such as the maximal
respiration rate, index of electron transport chain efficiency
(Invernizzi et al., 2012) measured in patient’s fibroblasts were
similar to controls. Over time his clinical conditions progressively
worsened, with severe reduction of the child’s reactivity to outer
FIGURE 3 | Mitochondrial network analysis in patient fibroblasts. Representative images of the mitochondrial network in fibroblasts from the patient (Pt) and a control
subject (Ct), cultured in either glucose (Upper) or galactose (Lower) medium. In the inset, a digital magnification (3x) shows the peculiar ‘chain-like’ structure
observed in Pt cells. Scale bar: 15µm.
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stimuli, a progressive worsening of the spasticity with loss of
head and trunk control and a reduction of the spontaneous
finalistic movements. Likewise, serial MRIs showed a progressive
worsening of brain lesions, with extension of the previously
described alterations and severe atrophy of corpus callosum
and cerebellum (Figures 1D–F). He suffered from epileptic
seizures characterized by focal lip myoclonus, startle reaction
and hypertonia of the limbs triggered by the awakening and
sudden acoustic stimuli. Asleep EEGs showedmultifocal epileptic
discharges. Suspecting a mitochondrial disorder, he started
antioxidant therapy with riboflavin (100 mg/day), thiamine (100
mg/kg/day), carnitine (100 mg/kg/day).
Genetic Analysis
Molecular analysis for mitochondrial DNA mutations associated
with MERRF (m.8344A>G) and NARP (m.8993T>G/T>C)
syndromes, and the complete sequencing of MT-ATP6 and
MT-ATP8 was negative. Because of the clinical presentation
suggesting a mitochondrial disorder, targeted resequencing of a
panel containing nuclear genes associated with mitochondrial
diseases was performed. Given the consanguinity of the parents
and the presence of two affected siblings, we hypothesized
a recessive trait and focused on rare homozygous variants:
only one nucleotide change was identified, c.892C>T, in MFF
(NM_020194). The variant was validated by Sanger sequencing
and found to be heterozygous in both parents. The c.892C>T
nucleotide substitution is predicted to cause the synthesis of
a truncated protein, p.Arg298∗ (Figures 2A–D). It was present
in only 1 out of >120000 alleles in control population (ExAC
database), and already reported in a patient, who carried this
nonsense mutation compound heterozygous with a second
frameshift change (Koch et al., 2016).
Protein Studies
We evaluated MFF protein levels in lysates obtained from
fibroblasts; we used a polyclonal antibody against MFF that
recognizes multiple isoforms of MFF protein due to alternative
splicing (band size around 26–29 kDa and 35–38 kDa). Western
blot analysis showed the presence of truncated MFF isoforms in
the patient, who carries the homozygous variant p.Arg298∗, and
reduction of total amount ofMFF compared to controls. Notably,
the level of DRP1 was unaffected (Figures 2E,F).
FIGURE 4 | Morphometric analysis of peroxisomal staining in patient fibroblasts. Immunofluorescence staining with the anti-PMP70 antibody in fibroblasts from the
patient (Pt) and a control subject (Ct). In the insets, a digital magnification (3x) better shows the altered peroxisomal morphology observed in Pt cells. Scale bar:
15µm. Analysis of the shape factor (circularity) and mean area of the peroxisomal staining in fibroblasts from Pt and Ct are reported in the graphs. Data are presented
as mean ± SD.
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Morphology Analysis on Patient’s
Fibroblasts
We performed microscopy fluorescence studies on fibroblasts
and analyzed subcellular organelles by imaging software.
First, we stained mitochondria with a specific mitochondrial
dye (Mitotracker red CMXRos Invitrogen); we observed a
filamentous mitochondrial network in both patient and control
fibroblasts, with a similar value of circularity shape factor,
indicating an elongated network. Interestingly, at higher
magnification, the network of patient cells showed a “chain-
like” structure, not observed in controls (Figure 3), but already
reported in other mitochondrial fission defects such as those
due to mutations in DNM1L (Nasca et al., 2016). This finding
could indicate that the fission mechanism was initialized but
not concluded because of the loss of functional MFF. These
morphological alterations were even more evident after cell
TABLE 1 | Genetic findings and biochemical and phenotypic features of published cases with MFF mutations.
Patient P1 (Shamseldin et al.,
2012)*
P1 (Koch et al., 2016) P2 (Koch et al.,
2016)**
P3 (Koch et al.,
2016)**
Present paper
Consanguinity + – + + +
Origin Saudi Arabian Austrian Turkish Turkish Italian
MFF variants c.(190C>T);(190C>T)
p.(Gln64*);(Gln64*)
c.(184dup);(892C>T)
p.(Leu62Profs*13);
(Arg298*)
c.(453_454del);
(453_454del)
p.(Glu153Alafs*5);
(Glu153Alafs*5)
c.(453_454del);
(453_454del)
p.(Glu153Alafs*5);
(Glu153Alafs*5)
c.(892C>T);(892C>T)
p.(Arg298*);(Arg298*)
PHENOTYPIC FEATURES
Sex Male Male Male Male Male
Age at onset First year 4 months 4 months 11 months 9 months
Microcephaly + + + + +
Regression/loss of skills n.c. + + + +
Severe developmental
delay/intellectual disability
+ + + + +
Spasticity + + + + +
Growth retardation n.c. – – + +
West syndrome – + + – -
Other epileptic and
developmental encephalopathies
+ – – – +
External ophthalmoparesis – + + + +
Optic athopy + + –(9 months) + +
Peripheral neuropathy n.c. + n.d. + -
Movement disorder - - - - Upper limb dystonia
Brain MRI lesions Pallidum Putamen, pallidum,
caudate,
mesencephalon,
dentate nucleus optic
radiation, cerebellar
atrophy
Pallidum,
mesencephalon,
thalamus
Putamen, pallidum,
caudate, thalamus,
mesencephalon,
cerebellar atrophy
Putamen, caudate,
mesencephalon,
cerebellar atrophy
Increased brain la ctate
(liquor/MRS)
n.c. – n.d. n.d. +
LABORATORY FINDINGS
Increased plasma lactate – + + + +
MRC in muscle n.d. Normal n.d. Normal Slight increased SDH
MRC fibroblasts Normal n.d. n.d. n.d. Normal
VLCFA increased – – – n.d. –
Plasmalogens abnormal n.d. – n.d. n.d. –
Pristanic acid abnormal n.d. – n.d. n.d. –
Phytanic acid abnormal n.d. – n.d. n.d. –
Bile acid metabolites abnormal n.d. – n.d. n.d. –
Bone abnormalities n.d. – n.d. n.d. Osteoporosis
Kidney cysts n.d. – n.d. n.d. –
+, present; –, absent; CSF, cerebrospinal fluid; GMFCS, Gross Motor Function Classification System; MFF, mitochondrial fission factor; MRC, mitochondrial respiratory chain enzymes;
MRS, magnetic resonance spectroscopy; n.c., not commented; n.d., not determined; VLCFA, very long chain fatty acids. *A younger brother was reported as similarly delayed but
without any further description. **These cases are two siblings.
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growth in galactose medium, a condition that forces cells to
use mitochondrial respiratory chain to produce ATP rather than
glycolysis (Figure 3).
For visualization of peroxisomes, we performed
immunofluorescence staining using an antibody against
PMP70, a peroxisomal membrane protein. In contrast
with the normally punctuated staining observed in
control fibroblasts, patient’s cells revealed very elongated
organelles, almost filamentous. Morphometric analysis
showed reduced circularity shape factor and increased
area in the patient’s peroxisomes compared to control
(Figure 4).
DISCUSSION
MFF mutations are extremely rare and only five patients from
3 families have been described till now (Table 1). The first
cases were two brothers, in whom the genetic cause was
identified by autozygome analysis and exome sequencing being
part of a cohort of consanguineous cases of mitochondrial
disease (Shamseldin et al., 2012). These two patients carried a
homozygous nonsense mutation (p.Gln64∗); marked difference
in the mitochondrial and peroxisomal morphology was observed
in patient fibroblasts, indicating thatMFF defect was the cause of
the disease.
A singleton case and two additional siblings with
MFF mutations were later described (Koch et al., 2016).
Main features of these patients are early onset epileptic
encephalopathy, acquired microcephaly, optic atrophy, external
ophthalmoparesis, neuroradiological findings evocative of Leigh
syndrome, all together suggesting mitochondrial dysfunction
without impairment of the mitochondrial respiratory chain
(more details in Table 1).
Our patient is the first reported case with such a long
neurological follow-up. His clinical phenotype is quite similar
to previously reported cases, but the progression of symptoms
was slower; at 11 years of age only a mild dysphagia was
detected. Although his neurological phenotype was dominated by
spasticity, dystonic postures of the upper limb extremities were
present. Interestingly, an anti-oxidant therapy was started at the
age of 3, with a slight improvement of the general conditions of
the child. No detail about the use of anti-oxidant therapy in this
disorder was available in previous reports. Remarkably, hepatic
steatosis gradually remitted over the years and, at the age of
11, the patient did not present any notable hepatic functionality
alteration.
Mutations of genes involved in mitodynamics (e.g., OPA1,
DNM1L. . . ) may lead to overlapping clinical presentations often
including optic atrophy as isolated symptom or part of severe
multisystem disorders. This evidence has been explained by a
peculiar vulnerability of retinal ganglion cells to mitochondrial
dysfunction. Given the accessibility of the eye as a part of the
central nervous system, ophthalmologic examination has been
suggested for correct diagnosis of these complex clinical entities
(Bagli et al., 2017).
Our patient showed clinical features suggesting both
mitochondrial and peroxisomal damage but biochemical
analyses were less informative. Lactate was found elevated in CSF
and by brain spectroscopy, and moderately high on plasma, but
neither respiratory chain defects nor biomarkers of peroxisomal
dysfunction were observed. Similar results were obtained in the
other MFF patients, with plasma lactate only occasionally
increased and other biochemical values in the control
range.
The absence of overt mitochondrial and peroxisomal
biochemical impairment is in line with what is reported in
other disorders affecting the dynamics of intracellular organelles
(e.g. DNM1L mutations). Mitochondrial diseases typically affect
neurons because they are among the most energy-consuming
cell types; however, in addition to bioenergetics defects, there
are evidences indicating a key role of impaired mitodynamics
in neurodegenerative diseases, in particular mitochondrial
transport along axons. A block in mitochondrial fission (e.g.,
because of mutations inMFF or DNM1L), causing the formation
of larger organelles, may have deleterious effects on the mobility
of mitochondria, on synaptic homeostasis, on mitophagy (Sheng
and Cai, 2012; Itoh et al., 2013; Burté et al., 2015; Pellegrino and
Haynes, 2015).
Accordingly, the analysis performed on fibroblasts from our
patient (present paper) and other subjects with MFF mutations
(Shamseldin et al., 2012; Koch et al., 2016) clearly showed
that MFF alterations caused derangement of the morphology
of mitochondria and peroxisomes; this was particularly evident
in the latters, with an extremely filamentous appearance
which was more striking than the elongated peroxisomes
observed in DNM1L patients (Nasca et al., 2016). These
findings confirmed a crucial role for MFF in fission of these
organelles.
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